Feb 04
Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients…
Related Reading:
Feb 04
Levels of inflammatory proteins, so-called cytokines, are elevated in the blood even before the onset of arthritic rheumatism…
Related Reading:
Feb 02
A new testing method is being developed to detect cancer soon after the tumor has formed. It will identify characteristic substances in the blood which accompany a certain type of tumor. The first steps in the development have already been completed. The earlier the doctor finds the tumor, the better the patient’s chances of recovery…
Related Reading:
Feb 01
UroToday.com – The investigation of disseminated tumor cells in the peripheral blood, so-called circulating tumor cells (CTCs), has come more in focus recently. Small amounts of peripheral blood (16ml/patient) can easily be collected, and immunomagnetic enrichment of tumor cells followed by immunohistochemical detection on just one slide allows a fast and specific identification of CTCs…
Related Reading:
Feb 01
The discovery of a major player in the body’s regulation of iron levels should provide a new target for drugs that prevent common iron deficiency as well as rare, potentially deadly iron overload, researchers said…
Related Reading:
Jan 30
Keryx Biopharmaceuticals, Inc…
Related Reading:
Jan 29
It is second nature for most of us that exercise protects against heart attack and stroke, but researchers have spent 30 years unraveling the biochemistry behind the idea…
Related Reading:
Jan 29
The American Society of Hematology (ASH) now offers physicians who diagnose and treat blood disorders a new resource for earning continuing medical education (CME) credits while staying abreast of the latest clinical strategies in the rapidly changing field of hematology…
Related Reading:
Jan 28
US researchers have discovered a protein that appears to play an important role in regulating blood levels of iron and suggest it could be a new target for drugs to treat iron deficiency, which is quite common, as well as the much rarer opposite condition, iron overload. Corresponding author Dr…
Related Reading:
Jan 28
Bone marrow is a leading source of adult stem cells, which are increasingly used for research and therapeutic interventions, but extracting the cells is an arduous and often painful process…
Related Reading:
Recent Comments